Gain Therapeutics (GANX) has shared an update.
Matthias Alder, CEO of Gain Therapeutics, Inc., mutually agreed to step down on June 25, 2024, to explore new opportunities, triggering his automatic resignation from the Board. In his exit, Alder received a separation package including a year’s salary and continued benefits. Meanwhile, Gene Mack, the CFO, stepped in as Interim CEO without additional pay, and Dr. Khalid Islam was appointed as Executive Chairman to supervise Board performance and support the new interim executive leadership.
See more insights into GANX stock on TipRanks’ Stock Analysis page.
